| 000 | 01661 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513070826.0 | ||
| 264 | 0 | _c19940202 | |
| 008 | 199402s 0 0 eng d | ||
| 022 | _a0027-8874 | ||
| 024 | 7 |
_a10.1093/jnci/86.1.39 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCole, D J | |
| 245 | 0 | 0 |
_aPhase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancer. _h[electronic resource] |
| 260 |
_bJournal of the National Cancer Institute _cJan 1994 |
||
| 300 |
_a39-45 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aLeukocyte Count _xdrug effects |
| 650 | 0 | 4 |
_aMacrophage Colony-Stimulating Factor _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMonocytes _xdrug effects |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPlatelet Count _xdrug effects |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSanda, M G | |
| 700 | 1 | _aYang, J C | |
| 700 | 1 | _aSchwartzentruber, D J | |
| 700 | 1 | _aWeber, J | |
| 700 | 1 | _aEttinghausen, S E | |
| 700 | 1 | _aPockaj, B A | |
| 700 | 1 | _aKim, H I | |
| 700 | 1 | _aLevin, R D | |
| 700 | 1 | _aPogrebniak, H W | |
| 773 | 0 |
_tJournal of the National Cancer Institute _gvol. 86 _gno. 1 _gp. 39-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/86.1.39 _zAvailable from publisher's website |
| 999 |
_c8270563 _d8270563 |
||